Research Projects & Grants

  • A Comparative Evaluation of the Soluble Interleukin-2 Receptor (sIL-2R)/Cyclosporine Ratio versus sIL-2R Alone in the Detection of Cardiac Allograft Rejection, Role: PI, (09/1994 - 09/1995) Status: Completed

College/University

  • National Children's Study, Role: Co-investigator, University of California, Irvine, (09/2008 - 09/2012) Status: Closed
  • Cardiac Transplantation in Infancy, Role: Principal Investigator, University of Michigan, (07/2008 - 06/2009) Status: Closed

Federal

  • Pediatric heart transplantation: Transitioning to adult care (TRANSIT), Role: Investigator, Lurie Children's Hospital of Chicago, IL, (12/2016 - 12/2017) Status: Completed
  • Genetic contribution to graft and patient outcomes, Role: PI, National Institutes of Health/DHHS, (09/2012 - 09/2013) Status: Completed
  • Yearly survey of patients with hypoplastic left heart syndrome, Role: PI, National Institute of Mental Health/NIH/DHHS, (11/2005 - 11/2006) Status: Completed
  • Comprehensive testing of patients with hypoplastic left heart syndrome, Role: PI, National Institutes of Health/DHHS, (11/2005 - 11/2006) Status: Completed
  • Gap junction gene defects and pediatric heart disease, Role: Investigator, National Heart, Lung, and Blood Institute/NIH/DHHS, (02/2000 - 02/2001) Status: Completed
  • The Immunogenicity of Routine Vaccines in Immunosuppressed Pediatric Heart Transplant Patients, Role: PI, National Institutes of Health/DHHS, (04/1996 - 04/1997) Status: Completed

For Profit Organization

  • Pharmacokinetics and safety of valganciclovir (Valcyte®) in infant heart transplant recipients less than 4 months of age - protocol no. NP22523, Role: PI, Hoffmann-La Roche Inc., (01/2014 - 01/2015) Status: Completed
  • DEFEND2: Durable-response therapy evaluation for early or new onset Type I Diabetes, Role: Investigator, Tolerx, Inc, (01/2011 - 01/2012) Status: Completed
  • Use of Rituximab in pediatric solid organ recipients with post transplant lymphoproliferative disorders: an open label phase II multicenter non-randomized study, Role: PI, IDEC Pharmaceuticals Corporation, (01/2004 - 01/2005) Status: Completed

Internal

  • Pediatric heart transplant study group collaborative database, Role: Investigator, LLU Dept. of Pediatrics, (03/2025 - 03/2026) Status: Approved
  • Ending the HIV Epidemic in Black America: Qualitative Insights Following COVID-19, Role: Investigator, LLU Center for Nutrition, Healthy Lifestyles, and Disease Prevention, (02/2023 - 01/2024) Status: Completed
  • A Mixed-Methods Investigation of a Hybrid Work Model in Los Angeles, Role: Investigator, LLU Center for Nutrition, Healthy Lifestyles, and Disease Prevention, (01/2023 - 01/2024) Status: Completed
  • Epstein-Barr viremia treatment with oral valganciclovir and intravenous immune globulin in pediatric cardiac transplant patients, Role: Investigator, LLU Dept. of Pediatrics, (08/2021) Status: Approved
  • Pediatric traumatic brain injury dysregulates the molecular cues of white matter, Role: PD/PI, LLU School of Medicine, (06/2014 - 12/2016) Status: Closed
  • Effectiveness of ultrasound cardiac output monitoring device in screening for acute graft rejection in patients with orthotopic cardiac transplantation, Role: Investigator, LLU Dept. of Pediatrics, (04/2007 - 04/2008) Status: Completed
  • (INT) Pediatric Research Residual, Role: Principal Investigator, LLU Dept. of Pediatrics, (07/2006 - 06/2027) Status: Awarded
  • Comparison of homocysteine levels in heart transplant patients with and without cardiac allograft vasculopathy, Role: Investigator, LLU Dept. of Cardiopulmonary Sciences, (07/1999 - 07/2000) Status: Completed
  • Pediatric Heart Transplant Immunosuppressive Protocol. A Randomized, Prospective Comparison of Two Post-Transplant Cyclosporine Target Ranges and Their Effect on Rejection Rate, Renal Side-Effects and Infections in Pediatric Heart Transplant Recipients, Role: PI, LLU Dept. of Pediatrics, (12/1998 - 12/1999) Status: Completed
  • Post-transplant lymphoproliferative disease (PTLD) in pediatric solid organ transplant recipients, Role: PI, LLU Dept. of Pediatrics, (03/1998) Status: Completed

Non-Profit Organization

  • Fiscal Agent to Inland Empire Spectrum Disorder Collaborative, Role: Principal Investigator, Inland Empire Spectrum Disorder Assessment Center of Excellence, (10/2014 - 08/2018) Status: Closed
  • Pediatric Heart Transplantation: Transition to Adult Care, Role: Co-PD/PI, Ann & Robert H. Lurie Children's Hospital of Chicago, (07/2013 - 05/2017) Status: Closed